Stem (NYSE:STEM – Get Free Report) had its price objective dropped by analysts at Piper Sandler from $1.50 to $0.30 in a research report issued on Friday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. Piper Sandler’s target price would suggest a potential downside of 25.37% from the company’s previous close.
Other equities analysts also recently issued research reports about the stock. UBS Group reduced their price objective on shares of Stem from $1.00 to $0.60 and set a “buy” rating on the stock in a research note on Friday, November 8th. The Goldman Sachs Group cut their price target on shares of Stem from $0.75 to $0.65 and set a “neutral” rating on the stock in a research note on Friday, November 1st. Susquehanna increased their target price on Stem from $0.50 to $0.60 and gave the stock a “neutral” rating in a research report on Wednesday, October 16th. Evercore ISI lowered their price objective on shares of Stem from $9.00 to $5.00 and set an “outperform” rating for the company in a research report on Wednesday, August 7th. Finally, Barclays decreased their target price on shares of Stem from $4.00 to $1.00 and set an “equal weight” rating for the company in a research note on Friday, October 18th. Seven investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $1.67.
Get Our Latest Stock Report on Stem
Stem Trading Up 11.8 %
Institutional Investors Weigh In On Stem
Several institutional investors have recently bought and sold shares of STEM. Healthcare of Ontario Pension Plan Trust Fund grew its position in Stem by 15.7% in the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 167,298 shares of the company’s stock worth $366,000 after buying an additional 22,703 shares during the last quarter. Price T Rowe Associates Inc. MD raised its stake in Stem by 45.9% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 158,102 shares of the company’s stock valued at $347,000 after purchasing an additional 49,713 shares during the period. Levin Capital Strategies L.P. boosted its position in shares of Stem by 204.6% in the first quarter. Levin Capital Strategies L.P. now owns 390,000 shares of the company’s stock worth $854,000 after buying an additional 261,980 shares during the period. Tidal Investments LLC lifted its stake in Stem by 904.0% in the 1st quarter. Tidal Investments LLC now owns 121,741 shares of the company’s stock worth $267,000 after acquiring an additional 109,616 shares in the last quarter. Finally, Swedbank AB acquired a new stake in Stem in the first quarter valued at approximately $346,000. Institutional investors and hedge funds own 61.63% of the company’s stock.
About Stem
Stem, Inc operates as a digitally connected, intelligent, and renewable energy storage network provider worldwide. The company offers energy storage hardware sourced from original equipment manufacturers (OEMs); edge hardware to aid in the collection of site data and real-time operation and control of the site and other optional equipment; and Athena, a software platform, which offers battery hardware and software-enabled services to operate the energy storage systems.
Read More
- Five stocks we like better than Stem
- Roth IRA Calculator: Calculate Your Potential Returns
- Tesla Investors Continue to Profit From the Trump Trade
- ESG Stocks, What Investors Should Know
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- Overbought Stocks Explained: Should You Trade Them?
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Receive News & Ratings for Stem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stem and related companies with MarketBeat.com's FREE daily email newsletter.